Carl Regillo

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address833 Chestnut Street
Philadelphia PA 19107
Phone215-928-3300
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Durrani AF, Momenaei B, Wakabayashi T, Vemula S, Pandit SA, Hsu J, Ho AC, Spirn MJ, Klufas MA, Garg SJ, Vander JF, Regillo CD, Chiang A, Kuriyan AE, Yonekawa Y. Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema. Br J Ophthalmol. 2024 Feb 12. PMID: 38346854.
      Citations:    
    2. Regillo CD, Nijm LM, Shechtman DL, Kaiser PK, Karpecki PM, Ryan EH, Ip MS, Yeu E, Kim T, Rafieetary MR, Donnenfeld ED. Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel. Clin Ophthalmol. 2024; 18:325-335. PMID: 38332904.
      Citations:    
    3. Mandava NK, Kuriyan AE, Ho AC, Hsu J, Regillo CD, Klufas MA. Enhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema. Curr Opin Ophthalmol. 2024 Feb 01. PMID: 38345051.
      Citations:    
    4. Israilevich RN, Mansour H, Patel SN, Garg SJ, Klufas MA, Yonekawa Y, Regillo CD, Hsu J. Risk of Endophthalmitis Based on Cumulative Number of Anti-Vascular Endothelial Growth Factor Intravitreal Injections. Ophthalmology. 2024 Jan 03. PMID: 38182029.
      Citations:    
    5. Khanani AM, Boyer DS, Wykoff CC, Regillo CD, Busbee BG, Pieramici D, Danzig CJ, Joondeph BC, Major JC, Turpcu A, Kiss S. Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study. EClinicalMedicine. 2024 Jan; 67:102394. PMID: 38152412.
      Citations:    
    6. Mahmoudzadeh R, Williamson JE, Salabati M, Soares RR, Gupta OP, Regillo CD, Ho AC, Hsu J. OCT-Based Description of Spontaneous Reattachment of Macula-Off Tractional Retinal Detachment With Significant Vision Improvement. J Vitreoretin Dis. 2024 Jan-Feb; 8(1):101-104. PMID: 38223772.
      Citations:    
    7. Weng CY, Singh RP, Gillies MC, Regillo CD. Optimizing Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration: the Potential Value of Sustained Anti-VEGF Therapy. Ophthalmic Surg Lasers Imaging Retina. 2023 Nov; 54(11):654-659. PMID: 37956321.
      Citations:    
    8. Pandit SA, Momenaei B, Wakabayashi T, Mansour HA, Vemula S, Durrani AF, Pashaee B, Kazan AS, Ho AC, Klufas M, Regillo C, Yonekawa Y, Hsu J, Kuriyan A, Chiang A. Real-World Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration. Ophthalmol Retina. 2023 Oct 30. PMID: 37913992.
      Citations:    
    9. Kaiser PK, Karpecki PM, Regillo CD, Baumal C, Ryan EH, Ip MS, Modi Y, Yeu E, Nijm L, Farid M, Rebenitsch RL, Kim T, Shechtman DL, Nichols K, Schweitzer J, Dunbar MT, Rafieetary MR, Donnenfeld ED. Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment. BMJ Open Ophthalmol. 2023 Oct; 8(1). PMID: 37857560.
      Citations:    
    10. Park JG, Adrean SD, Begaj T, Capone A, Charles S, Chen SN, Chou HD, Cohen MN, Corona ST, Faia LJ, Garg SJ, Garretson BR, Gregori NZ, Haller JA, Houghton OM, Hsu J, Jo J, Kaiser RS, Lai CC, Mahgoub MM, Mansoor M, Matoba R, Morizane Y, Nehemy MB, Raphaelian PV, Regillo CD, Ruby AJ, Runner MM, Sneed SR, Sohn EH, Spirn MJ, Vander JF, Wakabayashi T, Wolfe JD, Wykoff CC, Yonekawa Y, Yoon YH, Mahmoud TH. Surgical Management of Full Thickness Macular Holes in Macular Telangiectasia Type 2.A Global Multicenter Study. Ophthalmology. 2023 Sep 01. PMID: 37661066.
      Citations:    
    11. Awh KC, Mahmoudzadeh R, Salabati M, Mansour HA, Bechay J, Magagna J, Regillo CD, Ho AC, Garg SJ, Hsu J. Outcomes of Intentionally Suspending Treatment in Eyes With Advanced Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2023 Jul 28; 256:20-26. PMID: 37517527.
      Citations:    
    12. Wykoff CC, Garweg JG, Regillo C, Souied E, Wolf S, Dhoot DS, Agostini HT, Chang A, Laude A, Wachtlin J, Kovacic L, Wang L, Wang Y, Bouillaud E, Brown DM. KESTREL and KITE Phase 3 studies: 100-week results with brolucizumab in patients with diabetic macular edema. Am J Ophthalmol. 2023 Jul 15. PMID: 37460036.
      Citations:    
    13. Akhlaq A, Williams D, Clark WL, Khan H, Khanani AM, Walden L, Awh C, Graff JT, Graff JM, Wakabayashi T, Regillo C, Maass KF, Callaway N, Gune S, Campochiaro PA. Exudation in Patients with Neovascular Age-Related Macular Degeneration Treated with the Port Delivery System or Monthly Injections. Am J Ophthalmol. 2023 Jul 13. PMID: 37453472.
      Citations:    
    14. Wakabayashi T, Patel N, Bough M, Nahar A, Sheng Y, Momenaei B, Salabati M, Mahmoudzadeh R, Kuriyan AE, Spirn MJ, Chiang A, Hsu J, Fineman MS, Regillo CD, Sivalingam A, Ho AC, Gupta OP, Yonekawa Y. Vitrectomy for Vitreous Hemorrhage Associated with Retinal Vein Occlusion: Visual Outcomes, Prognostic Factors, and Sequelae. Retina. 2023 Jun 05. PMID: 37294906.
      Citations:    
    15. Wakabayashi T, Shiraki N, Tsuboi K, Oshima Y, Abe K, Yamamoto Y, Hisashi F, Baba K, Ishida Y, Otsuka Y, Shiraki A, Suzue M, Hashimoto R, Venkatesh R, Chhablani J, Gomi F, Kamei M, Maeno T, Regillo CD, Yonekawa Y, Ikuno Y. Risk Factors and Outcomes of Postoperative Macular Hole Formation after Vitrectomy for Myopic Traction Maculopathy: SCHISIS Report No. 2. Ophthalmol Retina. 2023 May 29. PMID: 37257585.
      Citations:    
    16. Wakabayashi T, Torjani A, Mahmoudzadeh R, Swaminathan S, Mansour HA, Salabati M, Yonekawa Y, Regillo CD. Risk Factors for Epiretinal Membrane After Rhegmatogenous Retinal Detachment Repair: Quantitative Ultra Widefield Imaging Analysis. Ophthalmic Surg Lasers Imaging Retina. 2023 04; 54(4):206-216. PMID: 37043411.
      Citations:    
    17. Vander JF, Fineman MS, Garg S, Regillo CD. Comment on: Perspective: A caveat about financial incentives for anti-vascular endothelial growth factor therapy for diabetic retinopathy. Am J Ophthalmol. 2023 Mar 03. PMID: 36871889.
      Citations:    
    18. Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC, Callaway NF, DeGraaf S, Ding HT, Fung AE, Gune S, Le Pogam S, Smith R, Willis JR, Barteselli G. Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results. Ophthalmology. 2023 Mar 02. PMID: 36870451.
      Citations:    
    19. Sharma A, Holz FG, Regillo CD, Freund KB, Sarraf D, Khanani AM, Baumal C, Holekamp N, Tadayoni R, Kumar N, Parachuri N, Kuppermann BD. Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER - survey). Expert Opin Biol Ther. 2023 Feb 19; 1-9. PMID: 36726203.
      Citations:    
    20. Shah SM, Eliott D, Cox JT, Yonekawa Y, Mahmoudzadeh R, Peck TJ, Regillo CD, Ho AC, Oellers P, Choudhury M, Arboleda N, Gentile RC, Sun V, Iezzi R. EPIRETINAL MEMBRANE WITH FOVEAL HERNIATION: Visual and Surgical Outcomes. Retina. 2023 02 01; 43(2):182-190. PMID: 36695789.
      Citations:    
    21. Wang R, McClard CK, Laswell S, Mahmoudzadeh R, Salabati M, Ammar M, Vannavong J, Aziz AA, Ewald A, Calvanese AV, Lehman EB, Fried S, Windham V, Strutt A, Saroj N, Khanani AM, Eichenbaum DA, Regillo C, Wykoff CC. Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). BMJ Open Ophthalmol. 2022 Dec; 7(1). PMID: 36794741.
      Citations:    
    22. Lee IJ, Pulido JS, Regillo CD, Leys M. Multiple organ dysfunction syndrome and disseminated intravascular coagulation causing extensive multiple Amalric triangular choroidal infarctions. Retin Cases Brief Rep. 2022 Nov 08. PMID: 36730731.
      Citations:    
    23. Salabati M, Mahmoudzadeh R, Starr MR, Zhang Q, Sharpe J, Hsu J, Ho AC, Regillo C, Kuriyan AE. REFRACTIVE ERROR CHANGE DURING TREATMENT OF DIABETIC MACULAR EDEMA: A Post Hoc Analysis of the Diabetic Retinopathy Clinical Research Protocol T Trial. Retina. 2022 11 01; 42(11):2059-2065. PMID: 36269800.
      Citations:    
    24. Sharma A, Kumar N, Parachuri N, Regillo C, Bandello F, Kuppermann BD. Biosimilar ranibizumab interchangeability: what does it mean to retinal physicians? Eye (Lond). 2022 Oct 17. PMID: 36253457.
      Citations:    
    25. Lim JI, Regillo CD, Sadda SR, Ipp E, Bhaskaranand M, Ramachandra C, Solanki K. Artificial Intelligence Detection of Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists' Dilated Examinations. Ophthalmol Sci. 2023 Mar; 3(1):100228. PMID: 36345378.
      Citations:    
    26. Gopal A, Starr M, Obeid A, Ryan E, Ryan C, Ammar M, Patel L, Forbes N, Capone A, Emerson G, Joseph D, Eliott D, Regillo C, Hsu J, Gupta O, Kuriyan A, Yonekawa Y. Predictors of Vision Loss after Surgery for Macula-Sparing Rhegmatogenous Retinal Detachment. Curr Eye Res. 2022 08; 47(8):1209-1217. PMID: 35608082.
      Citations:    
    27. Sharma A, Parachuri N, Kumar N, Kuppermann BD, Bandello F, Regillo CD. The port delivery system with ranibizumab: understanding nuances for clinical use in the real world. Expert Opin Biol Ther. 2022 06; 22(6):675-677. PMID: 35549582.
      Citations:    
    28. Regillo C, Singh R, Hamilton R, Gedif K, Best C, Koh A, Holz FG. Fluid Control in Neovascular Age-Related Macular Degeneration with Brolucizumab: An Analysis of the HAWK and HARRIER Phase 3 Trials. Ophthalmologica. 2022; 245(5):403-412. PMID: 35468601.
      Citations:    
    29. Israilevich RN, Starr MR, Mahmoudzadeh R, Salabati M, Swaminathan V, Huang D, Kuriyan AE, Yonekawa Y, Garg SJ, Mehta S, Regillo CD, Hsu J. Factors Associated With Good Visual Acuity Outcomes After Retinectomy in Eyes With Proliferative Vitreoretinopathy. Am J Ophthalmol. 2022 08; 240:143-148. PMID: 35288070.
      Citations:    
    30. Sharma A, Kumar N, Parachuri N, Regillo CD, Bandello F, Kuppermann BD. Retina: a unique subspecialty in the biosimilar landscape. Eye (Lond). 2022 06; 36(6):1145-1146. PMID: 35190669.
      Citations:    
    31. Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Lancet. 2022 02 19; 399(10326):729-740. PMID: 35085502.
      Citations:    
    32. Cai LZ, Lin J, Starr MR, Obeid A, Ryan EH, Ryan C, Forbes NJ, Arias D, Ammar MJ, Patel LG, Capone A, Emerson GG, Joseph DP, Eliott D, Gupta OP, Regillo CD, Hsu J, Yonekawa Y. PRO score: predictive scoring system for visual outcomes after rhegmatogenous retinal detachment repair. Br J Ophthalmol. 2021 Nov 23. PMID: 34815237.
      Citations:    
    33. Ipp E, Liljenquist D, Bode B, Shah VN, Silverstein S, Regillo CD, Lim JI, Sadda S, Domalpally A, Gray G, Bhaskaranand M, Ramachandra C, Solanki K. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy. JAMA Netw Open. 2021 11 01; 4(11):e2134254. PMID: 34779843.
      Citations:    
    34. Sharma A, Kumar N, Parachuri N, Karanam D, Kuppermann BD, Bandello F, Regillo CD. Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials. Eye (Lond). 2022 04; 36(4):679-680. PMID: 34718339.
      Citations:    
    35. Mahmoudzadeh R, Israilevich R, Salabati M, Hsu J, Garg SJ, Regillo CD, Ho AC, Khan MA. Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane: OCT Biomarkers of Visual Outcomes in 322 Eyes. Ophthalmol Retina. 2022 04; 6(4):308-317. PMID: 34718218.
      Citations:    
    36. Peck TJ, Starr MR, Yonekawa Y, Khan MA, Obeid A, Ryan EH, Ryan C, Ammar M, Patel LG, Forbes NJ, Capone A, Emerson GG, Joseph DP, Eliott D, Regillo CD, Hsu J, Gupta OP, Kuriyan AE. Outcomes of Primary Rhegmatogenous Retinal Detachment Repair in Eyes With Preoperative Grade B or C Proliferative Vitreoretinopathy. J Vitreoretin Dis. 2022 May-Jun; 6(3):194-200. PMID: 37008548.
      Citations:    
    37. Holekamp NM, Campochiaro PA, Chang MA, Miller D, Pieramici D, Adamis AP, Brittain C, Evans E, Kaufman D, Maass KF, Patel S, Ranade S, Singh N, Barteselli G, Regillo C. Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2022 03; 129(3):295-307. PMID: 34597713.
      Citations:    
    38. Starr MR, Ryan EH, Obeid A, Ryan C, Gao X, Madhava ML, Maloney SM, Adika AZ, Peddada KV, Sioufi K, Patel LG, Ammar MJ, Forbes NJ, Capone A, Emerson GG, Joseph DP, Eliott D, Regillo CD, Hsu J, Gupta OP, Yonekawa Y, Study Group FTPRDOP. Scleral Buckling for Primary Retinal Detachment: Outcomes of Scleral Tunnels versus Scleral Sutures. J Ophthalmic Vis Res. 2021 Jul-Sep; 16(3):377-383. PMID: 34394866.
      Citations:    
    39. Ammar MJ, Wu CM, Starr MR, Regillo CD. Central retinal vein occlusion after laparoscopic sleeve gastrectomy in an 18-year-Old female. Am J Ophthalmol Case Rep. 2021 Sep; 23:101165. PMID: 34368493.
      Citations:    
    40. Mahmoudzadeh R, Huang D, Salabati M, Awh K, Garg S, Hsu J, Ho A, Regillo C. Clinical Characteristics and Management Outcomes of Rhegmatogenous Retinal Detachments Due to Retinal Dialysis. J Vitreoretin Dis. 2021 Sep-Oct; 5(5):405-411. PMID: 37008705.
      Citations:    
    41. Starr MR, Ammar MJ, Patel LG, Boucher N, Yonekawa Y, Garg SJ, Hsu J, Ho AC, Regillo CD, Chiang A. Comparative Incidence of Postoperative Hemorrhage in Vitreoretinal Surgery in Patients on Anti-Coagulants. Ophthalmic Surg Lasers Imaging Retina. 2021 07; 52(7):374-379. PMID: 34309424.
      Citations:    
    42. Salabati M, Mahmoudzadeh R, Wong JC, Patel D, Patel SN, Obeid A, Sivalingam A, Vander JF, Garg SJ, Ho AC, Regillo CD, Hsu J. Outcomes of eyes with retinal vein occlusion that are lost to follow-up after antivascular endothelial growth factor therapy. Br J Ophthalmol. 2022 12; 106(12):1742-1747. PMID: 34183325.
      Citations:    
    43. Starr MR, Lee C, Arias D, Mahmoudzadeh R, Salabati M, Kuriyan AE, Regillo CD, Hsu J, Yonekawa Y, Gupta OP. Full-thickness macular holes after surgical repair of primary rhegmatogenous retinal detachments: incidence, clinical characteristics, and outcomes. Graefes Arch Clin Exp Ophthalmol. 2021 Nov; 259(11):3305-3310. PMID: 34151384.
      Citations:    
    44. Anaya JA, Regillo CD, Haller JA. Re: Berkowitz et?al: Cost Analysis of Routine Vitrectomy Surgery (Ophthalmology Retina. 2021;5:496-502). Ophthalmol Retina. 2021 07; 5(7):e8-e9. PMID: 34243975.
      Citations:    
    45. Starr MR, Cai L, Obeid A, Ryan EH, Eliott D, Ryan C, Forbes NJ, Ammar M, Patel LG, Capone A, Emerson GG, Joseph DP, Gupta OP, Regillo CD, Hsu J, Yonekawa Y. Risk Factors for Presence of Cystoid Macular Edema following Rhegmatogenous Retinal Detachment Surgery. Curr Eye Res. 2021 12; 46(12):1867-1875. PMID: 33979556.
      Citations:    
    46. Sharma A, Kumar N, Parachuri N, Singh S, Bandello F, Regillo CD, Boyer D, Nguyen QD. Understanding Retinal Vasculitis Associated with Brolucizumab: Complex Pathophysiology or Occam's Razor? Ocul Immunol Inflamm. 2022 Aug; 30(6):1508-1510. PMID: 34014141.
      Citations:    
    47. Patel SN, Starr MR, Obeid A, Ryan EH, Ryan C, Forbes NJ, Soares RR, Ammar M, Patel LG, Capone A, Emerson GG, Joseph DP, Eliott D, Regillo CD, Gupta OP, Hsu J, Yonekawa Y. CHARACTERISTICS AND SURGICAL OUTCOMES OF RHEGMATOGENOUS RETINAL DETACHMENT IN OLDER ADULTS: A Multicenter Comparative Cohort Study. Retina. 2021 May 01; 41(5):947-956. PMID: 32858667.
      Citations:    
    48. Soares RR, Gopal AD, Parikh D, Shields CN, Patel S, Hinkle J, Sharpe J, Ho AC, Regillo CD, Haller J, Yonekawa Y. Geographic Access Disparities of Clinical Trials in Neovascular Age-Related Macular Degeneration in the United States. Am J Ophthalmol. 2021 09; 229:160-168. PMID: 33848533.
      Citations:    
    49. Borkar DS, Berrocal MH, Rahimy E, Xu D, Regillo CD. Macular Mobilization with a Flexible Nitinol Loop for Chronic or Recurrent Macular Holes. Ophthalmol Retina. 2021 10; 5(10):1056-1058. PMID: 33848649.
      Citations:    
    50. McClard CK, Wang R, Windham V, Munoz J, Gomez S, Fried S, Saroj N, Regillo C, Wykoff CC, Strutt AM. Questionnaire to Assess Life Impact of Treatment by Intravitreal Injections (QUALITII): Development of a patient-reported measure to assess treatment burden of repeat intravitreal injections. BMJ Open Ophthalmol. 2021; 6(1):e000669. PMID: 33912685.
      Citations:    
    51. Sharma A, Parachuri N, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo CD, Chakravarthy U. Terms non-exudative and non-neovascular: awaiting entry at the doors of AMD reclassification. Graefes Arch Clin Exp Ophthalmol. 2021 06; 259(6):1381-1383. PMID: 33744982.
      Citations:    
    52. Starr MR, Hsu J, Yonekawa Y, Mittra RA, Ryan C, Forbes NJ, Ammar M, Patel LG, Obeid A, Capone A, Emerson GG, Joseph DP, Eliott D, Gupta OP, Regillo CD, Ryan EH. Surgical techniques for primary rhegmatogenous retinal detachments between surgeons with high versus low single surgery success rates. Acta Ophthalmol. 2021 Dec; 99(8):e1501-e1508. PMID: 33720540.
      Citations:    
    53. Starr MR, Obeid A, Ryan EH, Ryan C, Ammar M, Patel LG, Forbes NJ, Capone A, Emerson GG, Joseph DP, Eliott D, Gupta OP, Regillo CD, Hsu J, Yonekawa Y. RETINAL DETACHMENT WITH INFERIOR RETINAL BREAKS: Primary Vitrectomy Versus Vitrectomy With Scleral Buckle (PRO Study Report No. 9). Retina. 2021 Mar 01; 41(3):525-530. PMID: 33600131.
      Citations:    
    54. Sharma A, Kumar N, Parachuri N, Kuppermann BD, Bandello F, Regillo CD, Boyer D, Nguyen QD. Brolucizumab-foreseeable workflow in the current scenario. Eye (Lond). 2021 Jun; 35(6):1548-1550. PMID: 33531697.
      Citations:    
    55. Starr MR, Yonekawa Y, Obeid A, Ryan EH, Ryan C, Ammar M, Patel LG, Forbes NJ, Capone A, Emerson GG, Joseph DP, Eliott D, Regillo CD, Hsu J, Gupta OP, Kuriyan AE. Comparison of Visual and Anatomic Outcomes Following RRD Surgery Using 23-Gauge Versus 25-Gauge Vitrectomy: PRO Study Report No. 12. Ophthalmic Surg Lasers Imaging Retina. 2021 02 01; 52(2):70-76. PMID: 33626167.
      Citations:    
    56. Kuley B, Storey PP, Wibbelsman TD, Pancholy M, Zhang QE, Sharpe J, Bello N, Obeid A, Regillo C, Kaiser RS, Chiang A, Fineman MS, Vander JF, Gupta OP, Spirn MJ, Dunn JP, Mehta S, Park CH, Maguire JI, Garg S. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide. Curr Eye Res. 2021 06; 46(6):824-830. PMID: 33522311.
      Citations:    
    57. Sharma A, Parachuri N, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo CD, Chakravarthy U. Vortex vein anastomosis and pachychoroid-an evolving understanding. Eye (Lond). 2021 Jun; 35(6):1545-1547. PMID: 33514903.
      Citations:    
    58. Sharma A, Parachuri N, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo C, Chakravarthy U. Fluid-based prognostication in n-AMD: Type 3 macular neovascularisation needs an analysis in isolation. Br J Ophthalmol. 2021 03; 105(3):297-298. PMID: 33293272.
      Citations:    
    59. Mellen PL, Obeid A, Wibbelsman TD, Hsu J, Konkoly MA, Velez MR, Calem DB, Sioufi K, Jenkins TL, Xu D, Chiang A, Gupta OP, Spirn M, Regillo CD, Ho AC, Klufas MA. Clinical Outcomes of Eyes With Diabetic Macular Edema Switched From Aflibercept to Ranibizumab Therapy. Ophthalmic Surg Lasers Imaging Retina. 2020 12 01; 51(12):691-697. PMID: 33339050.
      Citations:    
    60. Patel SN, Mahmoudzadeh R, Salabati M, Soares RR, Hinkle J, Hsu J, Garg SJ, Regillo CD, Ho AC, Cohen MN, Khan MA, Yonekawa Y, Chiang A, Gupta OP, Kuriyan AE. Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections. Am J Ophthalmol. 2021 03; 223:178-183. PMID: 33129809.
      Citations:    
    61. Patel LG, Peck T, Starr MR, Ammar MJ, Khan MA, Yonekawa Y, Klufas MA, Regillo CD, Ho AC, Xu D. Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic: A Historical Cohort Study. Ophthalmology. 2021 05; 128(5):686-692. PMID: 33058938.
      Citations:    
    62. Patel D, Borkar DS, Madhava M, Obeid A, Mellen PL, Regillo CD, Garg SJ. Incidence of Management Changes at the Postoperative Day One Visit After Pars Plana Vitrectomy for Retinal Detachment. Am J Ophthalmol. 2021 02; 222:271-276. PMID: 33002487.
      Citations:    
    63. Sharma A, Parachuri N, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo CD, Chakravarthy U. Notion of tolerating subretinal fluid in neovascular AMD: understanding the fine print before the injection pause. Br J Ophthalmol. 2021 02; 105(2):149-150. PMID: 32980815.
      Citations:    
    64. Patel SN, Hsu J, Sivalingam MD, Chiang A, Kaiser RS, Mehta S, Park CH, Regillo CD, Sivalingam A, Vander JF, Ho AC, Garg SJ. The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2021 02; 222:194-201. PMID: 32888902.
      Citations:    
    65. Starr MR, Obeid A, Ryan EH, Gao X, Matsunaga D, Madhava ML, Maloney SM, Adika AZ, Peddada KV, Sioufi K, Ammar M, Patel LG, Ryan C, Forbes NJ, Capone A, Emerson GG, Joseph DP, Eliott D, Regillo CD, Hsu J, Yonekawa Y, Gupta OP. Surgical Outcomes of Primary RRD With and Without Concurrent Full-Thickness Macular Hole (PRO Study Report No. 7). Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):500-505. PMID: 32955589.
      Citations:    
    66. Hsu J, Regillo CD. Poorer Outcomes in Real-World Studies of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2020 09; 127(9):1189-1190. PMID: 32828193.
      Citations:    
    67. Kuley B, Storey PP, Pancholy M, Bello N, Murphy J, Goodman J, Wibbelsman TD, Obeid A, Chiang A, Regillo C, Garg S. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone. Can J Ophthalmol. 2020 12; 55(6):480-485. PMID: 32853591.
      Citations:    
    68. Sharma A, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo CD. Brolucizumab: the road ahead. Br J Ophthalmol. 2020 12; 104(12):1631-1632. PMID: 32829303.
      Citations:    
    69. Starr MR, Obeid A, Gao X, Ryan EH, Shah GK, Ryan C, Madhava ML, Maloney SM, Adika AZ, Peddada KV, Sioufi K, Ammar M, Patel LG, Forbes NJ, Capone A, Emerson GG, Joseph DP, Eliott D, Regillo CD, Hsu J, Gupta OP, Yonekawa Y. Prophylactic internal limiting membrane peeling during rhegmatogenous retinal detachment surgery. Acta Ophthalmol. 2021 Jun; 99(4):e619-e620. PMID: 32749767.
      Citations:    
    70. Matsunaga DR, Su D, Sioufi K, Obeid A, Wibbelsman T, Ho AC, Regillo CD. The Timing of Large Submacular Hemorrhage Secondary to Age-Related Macular Degeneration Relative to Anti-VEGF Therapy. Ophthalmol Retina. 2021 04; 5(4):342-347. PMID: 32763426.
      Citations:    
    71. Sharma A, Kumar N, Singh S, Regillo CD, Freund KB. Management of Fluid in Neovascular Age-related Macular Degeneration: To Mop it, to Dab it, or to Leave it? Retina. 2020 Aug; 40(8):1451-1455. PMID: 32568979.
      Citations:    
    72. Xu D, Levin HJ, Garrigan H, Wibbelsman TD, Obeid A, Pandit RR, Jenkins TL, Mehta S, Ho AC, Hsu J, Regillo CD. Outcomes and Complications of In-Office Laser Demarcation of Peripheral Rhegmatogenous Retinal Detachments. Ophthalmic Surg Lasers Imaging Retina. 2020 08 01; 51(8):428-434. PMID: 32818274.
      Citations:    
    73. Gopal AD, Wallach JD, Shah SA, Regillo C, Ross JS. On-Label and Off-Label Clinical Studies of FDA-Approved Ophthalmic Therapeutics. Ophthalmology. 2021 02; 128(2):332-334. PMID: 32682839.
      Citations:    
    74. Tieger MG, Rodriguez M, Wang JC, Obeid A, Ryan C, Gao X, Kakulavarapu S, Mardis PJ, Madhava ML, Maloney SM, Adika AZ, Peddada KV, Sioufi K, Stefater JA, Forbes NJ, Capone A, Emerson GG, Joseph DP, Regillo C, Hsu J, Gupta O, Eliott D, Ryan EH, Yonekawa Y. Impact of contact versus non-contact wide-angle viewing systems on outcomes of primary retinal detachment repair (PRO study report number 5). Br J Ophthalmol. 2021 03; 105(3):410-413. PMID: 32409294.
      Citations:    
    75. Joseph DP, Ryan EH, Ryan CM, Forbes NJK, Wagley S, Yonekawa Y, Mittra RA, Parke DW, Emerson GG, Shah GK, Blinder KJ, Capone A, Williams GA, Eliott D, Gupta OP, Hsu J, Regillo CD. Primary Retinal Detachment Outcomes Study: Pseudophakic Retinal Detachment Outcomes: Primary Retinal Detachment Outcomes Study Report Number 3. Ophthalmology. 2020 11; 127(11):1507-1514. PMID: 32437865.
      Citations:    
    76. Ammar MJ, Hsu J, Chiang A, Ho AC, Regillo CD. Age-related macular degeneration therapy: a review. Curr Opin Ophthalmol. 2020 May; 31(3):215-221. PMID: 32205470.
      Citations:    
    77. Kuley B, Storey PP, Pancholy M, Wibbelsman TD, Obeid A, Regillo C, Garg S. Treatment of Eyes With Diabetic Macular Edema That Had a Suboptimal Response to Antivascular Endothelial Growth Factor Therapy: 2-mg Intravitreal Triamcinolone Acetonide vs 0.7-mg Dexamethasone Implant. J Vitreoretin Dis. 2020 Sep-Oct; 4(5):372-376. PMID: 37008292.
      Citations:    
    78. Ryan EH, Ryan CM, Forbes NJ, Yonekawa Y, Wagley S, Mittra RA, Parke DW, Joseph DP, Emerson GG, Shah GK, Blinder KJ, Capone A, Williams GA, Eliott D, Gupta OP, Hsu J, Regillo CD. Primary Retinal Detachment Outcomes Study Report Number 2: Phakic Retinal Detachment Outcomes. Ophthalmology. 2020 08; 127(8):1077-1085. PMID: 32312634.
      Citations:    
    79. Ryan EH, Joseph DP, Ryan CM, Forbes NJK, Yonekawa Y, Mittra RA, Parke DW, Ringeisen A, Emerson GG, Shah GK, Blinder KJ, Capone A, Williams GA, Eliott D, Gupta OP, Hsu J, Regillo CD. Primary Retinal Detachment Outcomes Study: Methodology and Overall Outcomes-Primary Retinal Detachment Outcomes Study Report Number 1. Ophthalmol Retina. 2020 08; 4(8):814-822. PMID: 32513637.
      Citations:    
    80. Sharma A, Kumar N, Parachuri N, Sharma R, Bandello F, Kuppermann BD, Regillo CD. Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD). Eye (Lond). 2020 08; 34(8):1310-1312. PMID: 32132677.
      Citations:    
    81. Kuley B, Storey PP, Pancholy M, Obeid A, Murphy J, Goodman J, Wibbelsman TD, Regillo C, Chiang A. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone. Semin Ophthalmol. 2020 Feb 17; 35(2):141-146. PMID: 32343619.
      Citations:    
    82. Storey PP, Obeid A, Pancholy M, Goodman J, Borkar D, Su D, Regillo C. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE. Retina. 2020 Jan; 40(1):75-79. PMID: 30308561.
      Citations:    
    83. Sharma A, Hafeez Faridi M, Kumar N, Parachuri N, Sharma R, Kuppermann BD, Bandello F, Loewenstein A, Regillo CD. Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data. Eye (Lond). 2020 06; 34(6):1008-1009. PMID: 31844168.
      Citations:    
    84. Deaner JD, Aderman CM, Bonafede L, Regillo CD. PPV, Retinectomy, and Silicone Oil Without Scleral Buckle for Recurrent RRD From Proliferative Vitreoretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2019 11 01; 50(11):e278-e287. PMID: 31755979.
      Citations:    
    85. Patel SN, Wu C, Obeid A, Sivalingam M, Gervasio K, Wibbelsman TD, Levin H, Xu D, Regillo CD, Hsu J, Ho AC. Sociodemographic Factors in Neovascular Age-Related Macular Degeneration. Ophthalmology. 2020 02; 127(2):280-282. PMID: 31785890.
      Citations:    
    86. Borkar DS, Wibbelsman TD, Buch PM, Rapuano SB, Obeid A, Ho AC, Hsu J, Regillo CD, Ayres BD, Hammersmith KM, Nagra PK, Raber IM, Rapuano CJ, Syed ZA. Reply to: Endophthalmitis Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty. Am J Ophthalmol. 2019 11; 207:426-427. PMID: 31543217.
      Citations:    
    87. Sharma A, Parachuri N, Kumar N, Kuppermann BD, Bandello F, Loewenstein A, Regillo CD. Subfoveal Neurosensory Detachment Flattening and Observe (SNF-Ob): A Novel Approach in Diabetic Macular Edema Management: A Potential Cost-Effective Treatment Strategy to Be Explored. Ophthalmol Retina. 2019 11; 3(11):1009-1011. PMID: 31451440.
      Citations:    
    88. Sharma A, Kumar N, Parachuri N, Kuppermann BD, Bandello F, Regillo CD. Ranibizumab port delivery system (RPDS): realising long awaited dream of prolonged VEGF suppression. Eye (Lond). 2020 03; 34(3):422-423. PMID: 31165769.
      Citations:    
    89. Borkar DS, Wibbelsman TD, Buch PM, Rapuano SB, Obeid A, Ho AC, Hsu J, Regillo CD, Ayres BD, Hammersmith KM, Nagra PK, Raber IM, Rapuano CJ, Syed ZA. Endophthalmitis Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty. Am J Ophthalmol. 2019 09; 205:82-90. PMID: 31082349.
      Citations:    
    90. Khan MA, Gupta OP, Pendi K, Chiang A, Vander J, Regillo CD, Hsu J. PARS PLANA VITRECTOMY WITH ANTERIOR CHAMBER VERSUS GORE-TEX SUTURED POSTERIOR CHAMBER INTRAOCULAR LENS PLACEMENT: Long-Term Outcomes. Retina. 2019 May; 39(5):860-866. PMID: 29346243.
      Citations:    
    91. Shields RA, Tang PH, Regillo CD, Silva RA. Displacement of Submacular Hemorrhage With Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade in the Setting of Myopic Degeneration. Ophthalmic Surg Lasers Imaging Retina. 2019 04 01; 50(4):257-259. PMID: 30998250.
      Citations:    
    92. Campochiaro PA, Marcus DM, Awh CC, Regillo C, Adamis AP, Bantseev V, Chiang Y, Ehrlich JS, Erickson S, Hanley WD, Horvath J, Maass KF, Singh N, Tang F, Barteselli G. The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial. Ophthalmology. 2019 08; 126(8):1141-1154. PMID: 30946888.
      Citations:    
    93. Talcott KE, Obeid A, Gao X, Adika A, Regillo CD. Pars Plana Vitrectomy Alone for Primary Rhegmatogenous Retinal Detachments Associated With Inferior Breaks in Phakic Eyes. Ophthalmic Surg Lasers Imaging Retina. 2019 03 01; 50(3):153-158. PMID: 30893448.
      Citations:    
    94. London NJS, Kaiser RS, Khan MA, Alshareef RA, Khuthaila M, Shahlaee A, Obeid A, London VA, DeCroos FC, Gupta OP, Hsu J, Vander JF, Spirn MJ, Regillo CD. Determining the effect of low-dose isotretinoin on proliferative vitreoretinopathy: the DELIVER trial. Br J Ophthalmol. 2019 09; 103(9):1306-1313. PMID: 30381390.
      Citations:    
    95. Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD, Kaiser RS, Garg SJ, Hsu J. Reply. Am J Ophthalmol. 2018 12; 196:211-212. PMID: 30274784.
      Citations:    
    96. Aderman CM, Rahimy E, Obeid A, Gao X, Hsu J, Garg SJ, Regillo CD, Gupta OP, Chiang A. Comparing 33-Gauge versus 30-Gauge Needles for Intravitreal Injections. Ophthalmol Retina. 2018 10; 2(10):1078-1079. PMID: 31047499.
      Citations:    
    97. Obeid A, Su D, Patel SN, Uhr JH, Borkar D, Gao X, Fineman MS, Regillo CD, Maguire JI, Garg SJ, Hsu J. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmology. 2019 03; 126(3):407-413. PMID: 30077614.
      Citations:    
    98. Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD, Kaiser RS, Garg SJ, Hsu J. Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2018 10; 194:1-6. PMID: 29981738.
      Citations:    
    99. Khan MA, Durrani AK, Hsu J, Regillo CD. 27-GAUGE VITRECTOMY WOUND INTEGRITY: A Randomized Pilot Study Comparing Angled Versus Straight Entry in Fluid-Filled Vitrectomized Eyes. Retina. 2018 Apr; 38(4):678-683. PMID: 28358751.
      Citations:    
    100. Rayess N, Rahimy E, Ying GS, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J. Baseline choroidal thickness as a short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion. Br J Ophthalmol. 2019 01; 103(1):55-59. PMID: 29567791.
      Citations:    
    101. Khan MA, Kuley A, Riemann CD, Berrocal MH, Lakhanpal RR, Hsu J, Sivalingam A, Ho AC, Regillo CD. Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease. Ophthalmology. 2018 03; 125(3):423-431. PMID: 29146307.
      Citations:    
    102. Adam MK, Thornton S, Regillo CD, Park C, Ho AC, Hsu J. MINIMAL ENDOILLUMINATION LEVELS AND DISPLAY LUMINOUS EMITTANCE DURING THREE-DIMENSIONAL HEADS-UP VITREORETINAL SURGERY. Retina. 2017 Sep; 37(9):1746-1749. PMID: 27902640.
      Citations:    
    103. DeCroos FC, Reed D, Adam MK, Salz D, Gupta OP, Ho AC, Regillo CD. Reply. Am J Ophthalmol. 2017 10; 182:205-206. PMID: 28803629.
      Citations:    
    104. Yaspan BL, Williams DF, Holz FG, Regillo CD, Li Z, Dressen A, van Lookeren Campagne M, Le KN, Graham RR, Beres T, Bhangale TR, Honigberg LA, Smith A, Henry EC, Ho C, Strauss EC. Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration. Sci Transl Med. 2017 06 21; 9(395). PMID: 28637922.
      Citations:    
    105. DeCroos FC, Reed D, Adam MK, Salz D, Gupta OP, Ho AC, Regillo CD. Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration: A Prospective Clinical Trial. Am J Ophthalmol. 2017 Aug; 180:142-150. PMID: 28624325.
      Citations:    
    106. Wittenborn JS, Clemons T, Regillo C, Rayess N, Liffmann Kruger D, Rein D. Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System. JAMA Ophthalmol. 2017 05 01; 135(5):452-459. PMID: 28358948.
      Citations:    
    107. Regillo CD, Callanan DG, Do DV, Fine HF, Holekamp NM, Kuppermann BD, Singer MA, Singh RP. Use of Corticosteroids in the Treatment of Patients With Diabetic Macular Edema Who Have a Suboptimal Response to Anti-VEGF: Recommendations of an Expert Panel. Ophthalmic Surg Lasers Imaging Retina. 2017 04 01; 48(4):291-301. PMID: 28419394.
      Citations:    
    108. Ho AC, Albini TA, Brown DM, Boyer DS, Regillo CD, Heier JS. The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good. JAMA Ophthalmol. 2017 Mar 01; 135(3):268-273. PMID: 28114653.
      Citations:    
    109. Rayess N, Ying GS, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J, Rahimy E. Reply. Am J Ophthalmol. 2017 04; 176:258-259. PMID: 28190510.
      Citations:    
    110. Chiang A, Cohen MN, Houston SK, Juhn A, Ho AC, Regillo CD, Vander JF. Re: Effect of Aflibercept on Refractory Macular Edema Associated with Central Retinal Vein Occlusion. Can J Ophthalmol. 2017 02; 52(1):137-138. PMID: 28237140.
      Citations:    
    111. Rahimy E, Rayess N, Brady CJ, Regillo CD. Treat-and-Extend Regimen for Macular Edema Secondary to Central Retinal Vein Occlusion: 12-Month Results. Ophthalmol Retina. 2017 Mar - Apr; 1(2):118-123. PMID: 31047268.
      Citations:    
    112. Shields CL, Say EA, Pefkianaki M, Regillo CD, Caywood EH, Jabbour PM, Shields JA. RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture. Retina. 2016 Oct 26. PMID: 27787452.
      Citations:    
    113. Cohen MN, Houston SK, Juhn A, Ho AC, Regillo CD, Vander J, Chiang A. Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion. Can J Ophthalmol. 2016 Oct; 51(5):342-347. PMID: 27769324.
      Citations:    
    114. Rayess N, Rahimy E, Ying GS, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J. Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion. Am J Ophthalmol. 2016 Nov; 171:47-52. PMID: 27567889.
      Citations:    
    115. Jackson TL, Regillo CD, Girach A, Dugel PU. Baseline Predictors of Vitreomacular Adhesion/Traction Resolution Following an Intravitreal Injection of Ocriplasmin. Ophthalmic Surg Lasers Imaging Retina. 2016 08 01; 47(8):716-23. PMID: 27548448.
      Citations:    
    116. da Cruz L, Dorn JD, Humayun MS, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Ho AC, Brown G, Haller J, Regillo C, Del Priore LV, Arditi A, Greenberg RJ. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial. Ophthalmology. 2016 10; 123(10):2248-54. PMID: 27453256.
      Citations:    
    117. Shieh WS, Sridhar J, Hong BK, Maguire JI, Rahimy E, Shahlaee A, Ho AC, Hsu J, Regillo CD, Chiang A. Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications. Semin Ophthalmol. 2017; 32(5):614-619. PMID: 27367495.
      Citations:    
    118. Rahimy E, Shahlaee A, Khan MA, Ying GS, Maguire JI, Ho AC, Regillo CD, Hsu J. Reply. Am J Ophthalmol. 2016 08; 168:291-292. PMID: 27270363.
      Citations:    
    119. Moshfeghi DM, Kaiser PK, Michels S, Midena E, Kitchens JW, Prenner JL, Regillo CD, Reichel E. The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2016 06; 47(6 Suppl):S4-S14. PMID: 27348433.
      Citations:    
    120. Wykoff CC, Elman MJ, Regillo CD, Ding B, Lu N, Stoilov I. Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials. Ophthalmology. 2016 08; 123(8):1716-1721. PMID: 27208982.
      Citations:    
    121. Rahimy E, Rayess N, Ho AC, Regillo CD. TREATMENT OUTCOMES FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH INITIAL VISION BETTER THAN 20/40 USING A TREAT-AND-EXTEND REGIMEN. Retina. 2016 May; 36(5):875-80. PMID: 26630316.
      Citations:    
    122. Khan MA, Shahlaee A, Hsu J, Sivalingam A, Regillo CD, Ho AC, Toussaint B, Riemann CD, Dugel PU, Lakhanpal RR, Berrocal MH. Reply. Am J Ophthalmol. 2016 Apr; 164:145-6. PMID: 26944756.
      Citations:    
    123. Khan MA, Shahlaee A, Toussaint B, Hsu J, Sivalingam A, Dugel PU, Lakhanpal RR, Riemann CD, Berrocal MH, Regillo CD, Ho AC. Reply. Am J Ophthalmol. 2016 Apr; 164:148-9. PMID: 26897104.
      Citations:    
    124. Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, Dugel PU, Freund KB, Glassman AR, Kim JE, Martin DF, Pollack JS, Regillo CD, Rosenfeld PJ, Schachat AP, Wells JA. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice. JAMA Ophthalmol. 2016 Jan; 134(1):95-9. PMID: 26512939.
      Citations:    
    125. Rahimy E, Shahlaee A, Khan MA, Ying GS, Maguire JI, Ho AC, Regillo CD, Hsu J. Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema. Am J Ophthalmol. 2016 Apr; 164:118-27.e2. PMID: 26748058.
      Citations:    
    126. Greven MA, Garg S, Chiu B, Shah SP, Wolfe J, Fine HF, Roth DB, Robinson J, Mong J, Hsu J, Regillo C, Ho A, Haller JA. Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study. Br J Ophthalmol. 2016 Sep; 100(9):1211-5. PMID: 26659344.
      Citations:    
    127. Khan MA, Shahlaee A, Toussaint B, Hsu J, Sivalingam A, Dugel PU, Lakhanpal RR, Riemann CD, Berrocal MH, Regillo CD, Ho AC. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease. Am J Ophthalmol. 2016 Jan; 161:36-43.e1-2. PMID: 26429584.
      Citations:    
    128. Houston SK, Rayess N, Cohen MN, Ho AC, Regillo CD. INFLUENCE OF VITREOMACULAR INTERFACE ON ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY USING TREAT AND EXTEND TREATMENT PROTOCOL FOR AGE-RELATED MACULAR DEGENERATION (VINTREX). Retina. 2015 Sep; 35(9):1757-64. PMID: 26110596.
      Citations:    
    129. Rahimy E, Reddy S, DeCroos FC, Khan MA, Boyer DS, Gupta OP, Regillo CD, Haller JA. PROSPECTIVE EVALUATION OF VISUAL ACUITY AGREEMENT BETWEEN STANDARD EARLY TREATMENT DIABETIC RETINOPATHY STUDY CHART AND A HANDHELD EQUIVALENT IN EYES WITH RETINAL PATHOLOGY. Retina. 2015 Aug; 35(8):1680-7. PMID: 25719987.
      Citations:    
    130. Freund KB, Korobelnik JF, Devenyi R, Framme C, Galic J, Herbert E, Hoerauf H, Lanzetta P, Michels S, Mitchell P, Mon?s J, Regillo C, Tadayoni R, Talks J, Wolf S. TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations. Retina. 2015 Aug; 35(8):1489-506. PMID: 26076215.
      Citations:    
    131. Regillo CD, Busbee BG, Ho AC, Ding B, Haskova Z. Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration. Am J Ophthalmol. 2015 Nov; 160(5):1014-1023.e2. PMID: 26231305.
      Citations:    
    132. Ho AC, Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Brown GC, Haller JA, Regillo CD, Del Priore LV, Arditi A, Geruschat DR, Greenberg RJ. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind. Ophthalmology. 2015 Aug; 122(8):1547-54. PMID: 26162233.
      Citations:    
    133. Setlur VJ, Rayess N, Garg SJ, Hsu J, Luo CK, Regillo CD, Fineman MS, Sivalingam A. Combined 23-Gauge PPV and Scleral Buckle Versus 23-Gauge PPV Alone for Primary Repair of Pseudophakic Rhegmatogenous Retinal Detachment. Ophthalmic Surg Lasers Imaging Retina. 2015 Jul-Aug; 46(7):702-7. PMID: 26247450.
      Citations:    
    134. Boyer D, Freund KB, Regillo C, Levy MH, Garg S. Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration. Clin Ophthalmol. 2015; 9:1099-107. PMID: 26124633.
      Citations:    
    135. Pitcher JD, Khan MA, Storey PP, Hsiao-Fang-Yen N, Dollin ML, Hsu J, Ho AC, Regillo CD, Garg SJ. Contemporary Management of Rhegmatogenous Retinal Detachment Due to Giant Retinal Tears: A Consecutive Case Series. Ophthalmic Surg Lasers Imaging Retina. 2015 May; 46(5):566-70. PMID: 26057760.
      Citations:    
    136. Salz DA, Pitcher JD, Hsu J, Regillo CD, Fineman MS, Elliott KS, Vander JF, Fischer DH, Spirn MJ. Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. Ophthalmic Surg Lasers Imaging Retina. 2015 Apr; 46(4):439-44. PMID: 25970864.
      Citations:    
    137. Dugel PU, Regillo C, Eliott D. Characterization of Anatomic and Visual Function Outcomes in Patients With Full-Thickness Macular Hole in Ocriplasmin Phase 3 Trials. Am J Ophthalmol. 2015 Jul; 160(1):94-9.e1. PMID: 25818925.
      Citations:    
    138. Rahimy E, Fineman MS, Regillo CD, Spirn MJ, Hsu J, Kaiser RS, Maguire JI, Brown GC, Chiang A. Speculum versus Bimanual Lid Retraction during Intravitreal Injection. Ophthalmology. 2015 Aug; 122(8):1729-30. PMID: 25726752.
      Citations:    
    139. Sharma P, Juhn A, Houston SK, Fineman M, Chiang A, Ho A, Regillo C. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes. Am J Ophthalmol. 2015 May; 159(5):861-7.e2. PMID: 25660387.
      Citations:    
    140. Chang W, Garg SJ, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC, Maturi R. Reply: To PMID 24531021. Am J Ophthalmol. 2015 Feb; 159(2):404-5. PMID: 25542554.
      Citations:    
    141. Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015 Feb 07; 385(9967):509-16. PMID: 25458728.
      Citations:    
    142. DeCroos FC, Todorich B, Alshareef R, Khuthaila M, Fekrat S, Ho AC, Regillo CD, Spirn MJ. Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: a retrospective review. J Ophthalmic Vis Res. 2014 Oct-Dec; 9(4):461-8. PMID: 25709772.
      Citations:    
    143. Rayess N, Rahimy E, Ying GS, Bagheri N, Ho AC, Regillo CD, Vander JF, Hsu J. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am J Ophthalmol. 2015 Jan; 159(1):85-91.e1-3. PMID: 25261844.
      Citations:    
    144. Rayess N, Houston SK, Gupta OP, Ho AC, Regillo CD. Treatment outcomes after 3 years in neovascular age-related macular degeneration using a treat-and-extend regimen. Am J Ophthalmol. 2015 Jan; 159(1):3-8.e1. PMID: 25217859.
      Citations:    
    145. Ying GS, Kim BJ, Maguire MG, Huang J, Daniel E, Jaffe GJ, Grunwald JE, Blinder KJ, Flaxel CJ, Rahhal F, Regillo C, Martin DF. Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials. JAMA Ophthalmol. 2014 Aug; 132(8):915-21. PMID: 24875610.
      Citations:    
    146. Ho AC, Busbee BG, Regillo CD, Wieland MR, Van Everen SA, Li Z, Rubio RG, Lai P. Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology. 2014 Nov; 121(11):2181-92. PMID: 25015215.
      Citations:    
    147. Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol. 2014 Jun; 157(6):1250-7. PMID: 24531021.
      Citations:    
    148. Regillo CD. Eight questions with Dr. Puliafito. Ophthalmic Surg Lasers Imaging Retina. 2013 Mar-Apr; 44(2):215-6. PMID: 23510046.
      Citations:    
    149. Witkin AJ, London NJ, Wender JD, Fu A, Garg SJ, Regillo CD. Spectral-domain optical coherence tomography of white dot fovea. Arch Ophthalmol. 2012 Dec; 130(12):1603-5. PMID: 23229705.
      Citations:    
    150. Chiang A, Garg SJ, Alshareef RA, Pitcher JD, Hu AY, Spirn MJ, Hsu J, Lane RG, Regillo CD, Ho AC, Schwartz SD. Removal of posterior segment retained lens material using the OZil phacoemulsification handpiece versus Fragmatome during pars plana vitrectomy. Retina. 2012 Nov-Dec; 32(10):2119-26. PMID: 22718151.
      Citations:    
    151. Bansal AS, Bianciotto CG, Maguire JI, Regillo CD, Shields JA, Shields CL. Safety of pars plana vitrectomy in eyes with plaque-irradiated posterior uveal melanoma. Arch Ophthalmol. 2012 Oct; 130(10):1285-90. PMID: 23044941.
      Citations:    
    152. Bansal AS, Hsu J, Garg SJ, Sivalingam A, Vander JF, Moster M, Maguire JI, Regillo CD. Optic neuropathy after vitrectomy for retinal detachment: clinical features and analysis of risk factors. Ophthalmology. 2012 Nov; 119(11):2364-70. PMID: 22840420.
      Citations:    
    153. Lally DR, Gerstenblith AT, Regillo CD. Preferred therapies for neovascular age-related macular degeneration. Curr Opin Ophthalmol. 2012 May; 23(3):182-8. PMID: 22450218.
      Citations:    
    154. Orlin A, Hadley D, Chang W, Ho AC, Brown G, Kaiser RS, Regillo CD, Godshalk AN, Lier A, Kaderli B, Stambolian D. Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration. Retina. 2012 Jan; 32(1):4-9. PMID: 21878851.
      Citations:    
    155. Kaiser RS, Gupta OP, Regillo CD, Ho AC, Fineman MS, Vander JF, McNamara JA, Brown GC. Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response. Ophthalmic Surg Lasers Imaging. 2012 Jan-Feb; 43(1):13-9. PMID: 21986085.
      Citations:    
    156. Shienbaum G, Gupta OP, Fecarotta C, Patel AH, Kaiser RS, Regillo CD. Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact. Am J Ophthalmol. 2012 Mar; 153(3):468-473.e1. PMID: 21996309.
      Citations:    
    157. Rezeq SS, Vander JF, Hsu J, Regillo CD, Ho AC, Garg SJ, Spirn MJ. Iatrogrenic retinal breaks. Ophthalmology. 2011 Aug; 118(8):1696, 1696.e1; author reply 1697. PMID: 21813104.
      Citations:    
    158. Baker PS, Spirn MJ, Chiang A, Regillo CD, Ho AC, Vander JF, Kaiser RS. 23-Gauge transconjunctival pars plana vitrectomy for removal of retained lens fragments. Am J Ophthalmol. 2011 Oct; 152(4):624-7. PMID: 21726843.
      Citations:    
    159. Chiang A, Regillo CD. Preferred therapies for neovascular age-related macular degeneration. Curr Opin Ophthalmol. 2011 May; 22(3):199-204. PMID: 21427571.
      Citations:    
    160. Kitei PM, Say EA, Shields CL, Regillo CD, Shields JA. Management of retinal vasoproliferative tumor associated with ROP by plaque brachytherapy. J Pediatr Ophthalmol Strabismus. 2011 Feb 15; 48 Online:e10-2. PMID: 21323303.
      Citations:    
    161. Gupta OP, Shienbaum G, Patel AH, Fecarotta C, Kaiser RS, Regillo CD. A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact. Ophthalmology. 2010 Nov; 117(11):2134-40. PMID: 20591490.
      Citations:    
    162. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel EA, Brooks M, Baratz KH, Brown WL, Brucker AJ, Orlin A, Brown G, Ho A, Regillo C, Donoso L, Tian L, Kaderli B, Hadley D, Hagstrom SA, Peachey NS, Klein R, Klein BE, Gotoh N, Yamashiro K, Ferris Iii F, Fagerness JA, Reynolds R, Farrer LA, Kim IK, Miller JW, Cort?n M, Carracedo A, Sanchez-Salorio M, Pugh EW, Doheny KF, Brion M, Deangelis MM, Weeks DE, Zack DJ, Chew EY, Heckenlively JR, Yoshimura N, Iyengar SK, Francis PJ, Katsanis N, Seddon JM, Haines JL, Gorin MB, Abecasis GR, Swaroop A. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A. 2010 Apr 20; 107(16):7401-6. PMID: 20385819.
      Citations:    
    163. Kaiser RS, Prenner J, Scott IU, Brucker AJ, Flynn HW, Williams GA, Ho AC, Regillo CD, Capone A, Avery R, Eliott D, Dugel P, Pollack J. The Microsurgical Safety Task Force: evolving guidelines for minimizing the risk of endophthalmitis associated with microincisional vitrectomy surgery. Retina. 2010 Apr; 30(4):692-9. PMID: 20386097.
      Citations:    
    164. Ehlers JP, Spirn MJ, Shah CP, Fenton GL, Baker PS, Regillo CD, Ho AC. Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors. Ophthalmic Surg Lasers Imaging. 2010 Mar-Apr; 41(2):182-9. PMID: 20307035.
      Citations:    
    165. Hadley D, Orlin A, Brown G, Brucker AJ, Ho AC, Regillo CD, Donoso LA, Tian L, Kaderli B, Stambolian D. Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26. Invest Ophthalmol Vis Sci. 2010 Apr; 51(4):2191-6. PMID: 19933195.
      Citations:    
    166. Regillo CD, Leonard B. Progress in the management of major retinal disorders: highlights from the 2008 Sally Letson Symposium. Can J Ophthalmol. 2009 Jun; 44(3):251-4. PMID: 19491975.
      Citations:    
    167. Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS, Hollands H, Sharma S. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina. 2008 Nov-Dec; 28(10):1395-9. PMID: 18827737.
      Citations:    
    168. Ehlers JP, Kunimoto DY, Ittoop S, Maguire JI, Ho AC, Regillo CD. Metallic intraocular foreign bodies: characteristics, interventions, and prognostic factors for visual outcome and globe survival. Am J Ophthalmol. 2008 Sep; 146(3):427-433. PMID: 18614135.
      Citations:    
    169. Hsu J, Chen E, Gupta O, Fineman MS, Garg SJ, Regillo CD. Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes. Retina. 2008 Jul-Aug; 28(7):937-40. PMID: 18698294.
      Citations:    
    170. Gupta OP, Ho AC, Kaiser PK, Regillo CD, Chen S, Dyer DS, Dugel PU, Gupta S, Pollack JS. Short-term outcomes of 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2008 Aug; 146(2):193-197. PMID: 18547538.
      Citations:    
    171. Shah CP, Ho AC, Regillo CD, Fineman MS, Vander JF, Brown GC. Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment. Retina. 2008 May; 28(5):723-8. PMID: 18463516.
      Citations:    
    172. Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol. 2008 Feb; 145(2):239-248. PMID: 18222192.
      Citations:    
    173. Brown DM, Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol. 2007 Oct; 144(4):627-37. PMID: 17893015.
      Citations:    
    174. Hsu J, Kaiser RS, Sivalingam A, Abraham P, Fineman MS, Samuel MA, Vander JF, Regillo CD, Ho AC. Intravitreal bevacizumab (avastin) in central retinal vein occlusion. Retina. 2007 Oct; 27(8):1013-9. PMID: 18040237.
      Citations:    
    175. Ehlers JP, Fintak DR, Gupta OP, Regillo CD, Fineman MS, Ho AC. Pegaptanib for choroidal neovascularization in treatment-na?ve exudative age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2007 Sep-Oct; 38(5):371-7. PMID: 17955841.
      Citations:    
    176. Gupta OP, Weichel ED, Regillo CD, Fineman MS, Kaiser RS, Ho AC, McNamara JA, Vander JE. Postoperative complications associated with 25-gauge pars plana vitrectomy. Ophthalmic Surg Lasers Imaging. 2007 Jul-Aug; 38(4):270-5. PMID: 17674916.
      Citations:    
    177. Regillo CD, D'Amico DJ, Mieler WF, Schneebaum C, Beasley CH, Sullins GT. Clinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynamic therapy for treatment of wet age-related macular degeneration. Surv Ophthalmol. 2007 Jan; 52 Suppl 1:S70-8. PMID: 17240259.
      Citations:    
    178. Chhabra S, Kunimoto DY, Kazi L, Regillo CD, Ho AC, Belmont J, Maguire J, Vander J, Brown GC. Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates. Am J Ophthalmol. 2006 Nov; 142(5):852-4. PMID: 17056367.
      Citations:    
    179. Hurley BR, McNamara JA, Fineman MS, Ho AC, Tasman W, Kaiser RS, Vander JF, Regillo CD, Brown GC. Laser treatment for retinopathy of prematurity: evolution in treatment technique over 15 years. Retina. 2006 Sep; 26(7 Suppl):S16-7. PMID: 16946671.
      Citations:    
    180. Scartozzi R, Bessa AS, Gupta OP, Regillo CD. Intraoperative sclerotomy-related retinal breaks for macular surgery, 20- vs 25-gauge vitrectomy systems. Am J Ophthalmol. 2007 Jan; 143(1):155-6. PMID: 17188054.
      Citations:    
    181. Garg SJ, Regillo CD, Aggarwal S, Bilyk JR, Savino PJ. Macular exudative retinal detachment in a patient with a dural cavernous sinus fistula. Arch Ophthalmol. 2006 Aug; 124(8):1201-2. PMID: 16908829.
      Citations:    
    182. Lam A, Lee HC, Ho AC, Regillo CD, McNamara JA, Fineman MD. Photodynamic therapy in young patients. Ophthalmic Surg Lasers Imaging. 2006 May-Jun; 37(3):182-9. PMID: 16749253.
      Citations:    
    183. Smith BT, Vander JE, Regillo CD, Ho AC. Evaluation of the potential acuity meter in predicting visual acuity after photodynamic therapy for choroidal neovascularization. Ophthalmic Surg Lasers Imaging. 2006 Jan-Feb; 37(1):6-11. PMID: 16468545.
      Citations:    
    184. Chieh JJ, Roth DB, Liu M, Belmont J, Nelson M, Regillo C, Martidis A. Intravitreal triamcinolone acetonide for diabetic macular edema. Retina. 2005 Oct-Nov; 25(7):828-34. PMID: 16205559.
      Citations:    
    185. Anderson NG, Regillo C. Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol. 2004 Dec; 15(6):503-7. PMID: 15523196.
      Citations:    
    186. Sharma MC, Regillo CD, Shuler MF, Borrillo JL, Benson WE. Determination of the incidence and clinical characteristics of subsequent retinal tears following treatment of the acute posterior vitreous detachment-related initial retinal tears. Am J Ophthalmol. 2004 Aug; 138(2):280-4. PMID: 15289138.
      Citations:    
    187. Liu M, Regillo CD. A review of treatments for macular degeneration: a synopsis of currently approved treatments and ongoing clinical trials. Curr Opin Ophthalmol. 2004 Jun; 15(3):221-6. PMID: 15118509.
      Citations:    
    188. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina. 2003 Oct; 23(5):686-91. PMID: 14574256.
      Citations:    
    189. Connolly BP, Regillo CD, Eagle RC, Shields CL, Shields JA, Moran H. The histopathologic effects of transpupillary thermotherapy in human eyes. Ophthalmology. 2003 Feb; 110(2):415-20. PMID: 12578790.
      Citations:    
    190. Tennant MT, Borrillo JL, Regillo CD. Management of submacular hemorrhage. Ophthalmol Clin North Am. 2002 Dec; 15(4):445-52, vi. PMID: 12515076.
      Citations:    
    191. Ng EY, Connolly BP, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology. 2002 May; 109(5):928-34; discussion 935. PMID: 11986099.
      Citations:    
    192. Connolly BP, Ng EY, McNamara JA, Regillo CD, Vander JF, Tasman W. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology. 2002 May; 109(5):936-41. PMID: 11986101.
      Citations:    
    193. Aldave AJ, Gertner GS, Davis GH, Regillo CD, Jeffers JB. Bungee cord-associated ocular trauma. Ophthalmology. 2001 Apr; 108(4):788-92. PMID: 11297499.
      Citations:    
    194. Fineman MS, Vander J, Regillo CD, Fineman SW, Brown GC. Hypopyon uveitis in immunocompetent patients treated for Mycobacterium avium complex pulmonary infection with rifabutin. Retina. 2001; 21(5):531-3. PMID: 11642387.
      Citations:    
    195. Benson WE, Regillo CD, Vander JF, Tasman W, Smith AF, Brown GC, Ho AC, McNamara JA. Patient-initiated second medical opinions: their necessity and economic cost. Retina. 2001; 21(6):633-8. PMID: 11756887.
      Citations:    
    196. McCabe CM, Flynn HW, Shields CL, Shields JA, Regillo CD, McDonald HR, Berrocal MH, Gass JD, Mieler WF. Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes. Ophthalmology. 2000 Dec; 107(12):2240-8. PMID: 11097604.
      Citations:    
    197. Vander JF, Ho AC, McNamara JA, Regillo CD, Brown GC, Benson WE, Tasman W. Diabetes and retinopathy. Ophthalmology. 2000 Dec; 107(12):2120-2. PMID: 11097567.
      Citations:    
    198. Regillo CD. Update on photodynamic therapy. Curr Opin Ophthalmol. 2000 Jun; 11(3):166-70. PMID: 10977221.
      Citations:    
    199. Shah GK, Stein JD, Sharma S, Sivalingam A, Benson WE, Regillo CD, Brown GC, Tasman W. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology. 2000 Mar; 107(3):486-9. PMID: 10711885.
      Citations:    
    200. Fineman MS, Regillo CD, Sergott RC, Spaeth G, Vander J. Transient visual loss and decreased ocular blood flow velocities following a scleral buckling procedure. Arch Ophthalmol. 1999 Dec; 117(12):1647-8. PMID: 10604673.
      Citations:    
    201. Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, Blodi BA, Elner SG. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999 Oct; 106(10):1900-6; discussion 1906-7. PMID: 10519583.
      Citations:    
    202. Connolly BP, McNamara JA, Regillo CD, Tasman W, Sharma S. Visual outcomes after laser photocoagulation for threshold retinopathy of prematurity. Ophthalmology. 1999 Sep; 106(9):1734-7; discussion 1737-8. PMID: 10485543.
      Citations:    
    203. Regillo CD. The present role of indocyanine green angiography in ophthalmology. Curr Opin Ophthalmol. 1999 Jun; 10(3):189-96. PMID: 10537778.
      Citations:    
    204. Regillo CD, Blade KA, Custis PH, O'Connell SR. Evaluating persistent and recurrent choroidal neovascularization. The role of indocyanine green angiography. Ophthalmology. 1998 Oct; 105(10):1821-6. PMID: 9787349.
      Citations:    
    205. Connolly BP, McNamara JA, Sharma S, Regillo CD, Tasman W. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity. Ophthalmology. 1998 Sep; 105(9):1628-31. PMID: 9754168.
      Citations:    
    206. Regillo CD, Custis PH. Surgical management of retinoschisis. Curr Opin Ophthalmol. 1997 Jun; 8(3):80-6. PMID: 10168899.
      Citations:    
    207. Sharpe RW, Bethel KJ, Keefe KS, Hall FW, Levine EM, Regillo CD. Choroidal hematopoiesis in an adult. Arch Ophthalmol. 1996 Nov; 114(11):1421-2. PMID: 8906040.
      Citations:    
    208. Regillo CD, Tidwell J. A small-incision technique for suturing a posterior chamber intraocular lens. Ophthalmic Surg Lasers. 1996 Jun; 27(6):473-5. PMID: 8782263.
      Citations:    
    209. Borne MJ, Tasman W, Regillo C, Malecha M, Sarin L. Outcomes of vitrectomy for retained lens fragments. Ophthalmology. 1996 Jun; 103(6):971-6. PMID: 8643257.
      Citations:    
    210. Phillips WB, Regillo CD, Maguire JI. Indocyanine green angiography of idiopathic polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers. 1996 Jun; 27(6):467-70. PMID: 8782261.
      Citations:    
    211. Regillo CD, Brown GC, Savino PJ, Byrnes GA, Benson WE, Tasman WS, Sergott RC. Diabetic papillopathy. Patient characteristics and fundus findings. Arch Ophthalmol. 1995 Jul; 113(7):889-95. PMID: 7605280.
      Citations:    
    212. Gedde S, Regillo CD, Vander J. Advanced proliferative retinopathy and iris neovascularization in an intravenous drug abuser. Ophthalmic Surg. 1995 Jan-Feb; 26(1):85-7. PMID: 7538214.
      Citations:    
    213. Ho AC, Sergott RC, Regillo CD, Savino PJ, Lieb WE, Flaharty PM, Bosley TM. Color Doppler hemodynamics of giant cell arteritis. Arch Ophthalmol. 1994 Jul; 112(7):938-45. PMID: 8031274.
      Citations:    
    214. Regillo CD, Benson WE, Maguire JI, Annesley WH. Indocyanine green angiography and occult choroidal neovascularization. Ophthalmology. 1994 Feb; 101(2):280-8. PMID: 7509471.
      Citations:    
    215. Regillo CD, Tasman WS, Brown GC. Surgical management of complications associated with X-linked retinoschisis. Arch Ophthalmol. 1993 Aug; 111(8):1080-6. PMID: 8352691.
      Citations:    
    216. Regillo CD, Sergott RC, Ho AC, Belmont JB, Fischer DH. Hemodynamic alterations in the acute retinal necrosis syndrome. Ophthalmology. 1993 Aug; 100(8):1171-6. PMID: 8341497.
      Citations:    
    217. Regillo CD, Sergott RC, Brown GC. Successful scleral buckling procedures decrease central retinal artery blood flow velocity. Ophthalmology. 1993 Jul; 100(7):1044-9. PMID: 8321526.
      Citations:    
    218. Regillo CD, Eagle RC, Shields JA, Shields CL, Arbizo VV. Histopathologic findings in congenital grouped pigmentation of the retina. Ophthalmology. 1993 Mar; 100(3):400-5. PMID: 8460012.
      Citations:    
    219. Regillo CD, Vander JF, Duker JS, Fischer DH, Belmont JB, Kleiner R. Repair of retinitis-related retinal detachments with silicone oil in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992 Jan 15; 113(1):21-7. PMID: 1309409.
      Citations:    
    220. Regillo CD, Shields CL, Shields JA, Eagle RC, Lehr J. Ocular tuberculosis. JAMA. 1991 Sep 18; 266(11):1490. PMID: 1880877.
      Citations:    
    Regillo's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (431)
    Explore
    _
    Co-Authors (46)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _